These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 13730134)

  • 1. Clinical experience with triparanol.
    OAKS W; LISAN P; MOYER JH
    Postgrad Med; 1961 Jul; 30():76-82. PubMed ID: 13730134
    [No Abstract]   [Full Text] [Related]  

  • 2. A brief experience with triparanol (MER-29).
    STRAIGHT WM; LAHUIS NC
    J Fla Med Assoc (1914); 1961 Oct; 48():341-5. PubMed ID: 13917595
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experience with triparanol.
    BECKER MC
    J Med Soc N J; 1962 Feb; 59():59-64. PubMed ID: 13866353
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of triparanol to lower serum cholesterol.
    GOYETTE EM; ELDER JC
    Am Heart J; 1960 Oct; 60():536-8. PubMed ID: 13707585
    [No Abstract]   [Full Text] [Related]  

  • 5. Observations on the effect of triparanol (MER-29) on the serum cholesterol of selected human subjects.
    ROSENMAN RH; FRIEDMAN M
    Prog Cardiovasc Dis; 1960 May; 2():605-11. PubMed ID: 14439028
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of MER-29 (triparanol) on serum cholesterol, cholesterol esters and liver enzymes.
    RUSKIN A; RUSKIN B
    Prog Cardiovasc Dis; 1960 May; 2():624-30. PubMed ID: 14440267
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of triparanol on serum low-density lipoproteins and cholesterol.
    ENGELBERG H
    Geriatrics; 1962 Aug; 17():528-31. PubMed ID: 13890232
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of a cholesterol-synthesis inhibitor (triparanol).
    CARVER MJ; FREEMAN JG; SMITH JA
    Ann Intern Med; 1960 Sep; 53():462-7. PubMed ID: 13691207
    [No Abstract]   [Full Text] [Related]  

  • 9. [Action of triparanol on blood lipid changes].
    MARCHESE G
    G Gerontol; 1962 May; 10():449-61. PubMed ID: 14469633
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with MER-29, an inhibitor of cholesterol synthesis.
    ESTES JE
    Prog Cardiovasc Dis; 1960 May; 2():564-70. PubMed ID: 13820868
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical trials in atherosclerotics with Triparanol (MER-29) diminishing the biosynthesis of cholesterol].
    KELLER L; GERGELY J
    Z Gesamte Inn Med; 1962 Feb; 17():183-6. PubMed ID: 14454950
    [No Abstract]   [Full Text] [Related]  

  • 12. The metabolism of desmosterol in human subjects during triparanol administration.
    GOODMAN DS; AVIGAN J; WILSON H
    J Clin Invest; 1962 May; 41(5):962-71. PubMed ID: 13900301
    [No Abstract]   [Full Text] [Related]  

  • 13. The hypocholesterolemic effect of triparanol (MER-29) in man.
    RUSKIN A
    Arch Intern Med; 1960 Dec; 106():803-8. PubMed ID: 13744810
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies of serum desmosterol levels in hypercholesteremic subjects treated with triparanol (MER-29).
    Sachs BA; Wolfman L
    Am J Clin Nutr; 1961; 9():760-3. PubMed ID: 14495832
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical and biochemical research on the effects of triparanol (Merrel--29)].
    KNUECHEL F
    Med Welt; 1962 Feb; 7():367-76. PubMed ID: 14457393
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of triparanol and sodium dextrothyroxine to lower serum cholesterol.
    GOYETTE EM; SAAD A
    Angiology; 1962 Feb; 13():88-93. PubMed ID: 13900898
    [No Abstract]   [Full Text] [Related]  

  • 17. A clinical study of triparanol (MER-29).
    LISAN P; OAKS W; MOYER JH
    Am J Cardiol; 1960 Aug; 6():246-51. PubMed ID: 14417444
    [No Abstract]   [Full Text] [Related]  

  • 18. [Triparanol treatment of hypercholesterolemia].
    TRANSBOL I; WINKLER K; TYGSTRUP N
    Ugeskr Laeger; 1961 Aug; 123():1167-9. PubMed ID: 13777887
    [No Abstract]   [Full Text] [Related]  

  • 19. Acutte effects of triparanol in man.
    BLANKENHORN DH; KUZMA O
    Metabolism; 1961 Oct; 10():763-70. PubMed ID: 13869841
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experiences with Triparanol, a drug inhibiting cholesterol biosynthesis, in atherosclerotic patients].
    KELLER L; GERGELY J
    Orv Hetil; 1962 Apr; 103():690-2. PubMed ID: 14454951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.